132 related articles for article (PubMed ID: 10070711)
1. A trial study of leukocyte labeling with stabilized Tc-99m D,L-HMPAO by methylene blue and sodium phosphate buffer.
Kao CH; Huang WT; Wey SP; Changlai SP; Liao KK; Tsai CS
Appl Radiat Isot; 1999 Mar; 50(3):513-9. PubMed ID: 10070711
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
Kao CH; Huang WT; Tsai CS
Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis, viability, and labeling stability of leukocytes labeled with (99m)Tc-exametazime stabilized with methylene blue.
Roca M; Iglesias F; García V; Armero F; Díaz MC
J Nucl Med; 2001 Mar; 42(3):505-8. PubMed ID: 11337530
[TBL] [Abstract][Full Text] [Related]
4. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
5. Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes.
Hung JC; Iverson BC; Toulouse KA; Mahoney DW
J Nucl Med; 2002 Jul; 43(7):928-32. PubMed ID: 12097465
[TBL] [Abstract][Full Text] [Related]
6. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
8. Improvement of brain SPECT by stabilization of Tc-99m-HMPAO with methylene blue or cobalt chloride. Comparison with Tc-99m-ECD.
Barthel H; Kämpfer I; Seese A; Dannenberg C; Kluge R; Burchert W; Knapp WH
Nuklearmedizin; 1999 Apr; 38(3):80-4. PubMed ID: 10320993
[TBL] [Abstract][Full Text] [Related]
9. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
[TBL] [Abstract][Full Text] [Related]
11. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
Hung JC; Chowdhury S; Mullan BP
J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
[TBL] [Abstract][Full Text] [Related]
12. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of Tc-99m HMPAO labeled leukocyte imaging in inflammatory disease].
Aburano T; Taki J; Kinuya S; Shuke N; Yokoyama K; Takayama T; Tonami N; Hisada K; Terada H
Kaku Igaku; 1991 Oct; 28(10):1143-50. PubMed ID: 1800774
[TBL] [Abstract][Full Text] [Related]
14. [Screening with angiographic images prior to (99m)Tc-HMPAO labelled leukocyte scintigraphy in the diagnosis of periprosthetic infection].
Granados U; Fuster D; Soriano A; García S; Bori G; Martínez JC; Mayoral M; Perlaza P; Tomás X; Pons F
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):219-24. PubMed ID: 25563527
[TBL] [Abstract][Full Text] [Related]
15. The value of quantitative uptake of (99m)Tc-MDP and (99m)Tc-HMPAO white blood cells in detecting osteomyelitis in violated peripheral bones.
Ballani NS; Al-Huda FA; Khan HA; Al-Mohannadi S; Mahmood H; Al-Enezi F
J Nucl Med Technol; 2007 Jun; 35(2):91-5. PubMed ID: 17496004
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte Labeling with Tc-99m-HMPAO: The Role of Leucocyte Numbers and Medication on the Labeling Efficacy and Image Quality.
Karayel E; Ocak M; Birteksöz Tan AS
Mol Imaging Radionucl Ther; 2023 Feb; 32(1):28-34. PubMed ID: 36818059
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of Tc-99m-HMPAO-labeled leukocytes in cutaneous lesions of Henoch-Schonlein purpura.
Phan TT; Slart RH
Ann Nucl Med; 2006 Oct; 20(8):561-3. PubMed ID: 17134025
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.
Koslowsky IL; Brake SE; Bitner SJ
J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532
[TBL] [Abstract][Full Text] [Related]
19. The role of radiolabeled leukocyte imaging in the management of patients with acute appendicitis.
Kipper SL
Q J Nucl Med; 1999 Mar; 43(1):83-92. PubMed ID: 10230284
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Crohn disease.
Filippi L; Biancone L; Petruzziello C; Schillaci O
Clin Nucl Med; 2006 Sep; 31(9):541-2. PubMed ID: 16921278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
